Concepedia

Laurent Detalle

LD

11

Publications

717

Citations

11

H-Index

2007

Active since

Affiliations

Ablynx (Belgium)(Current)

Baylor College of Medicine

UCB Pharma (United Kingdom)

Queen's University Belfast

Iowa State University

Laurent Detalle is an author at Ablynx (Belgium) specializing in nanomanufacturing, engineering, and biomolecular engineering.

ORCID

Top concepts

Publications per year

2007–2022

11

Publications

11

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Laurent Detalle, Thomas Stöhr, Concepción Palomo et al. · Antimicrobial Agents and Chemotherapy · 2015 · 289 citations · Full text

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

Steve Cunningham, Pedro A. Piedra, Federico Martinón‐Torres et al. · The Lancet Respiratory Medicine · 2020 · 123 citations · Full text

, , +8

Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs

Alejandro Larios Mora, Laurent Detalle, Jack M. Gallup et al. · mAbs · 2018 · 95 citations · Full text

Phase 1/1b Studies of <scp>UCB0599</scp>, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

Johan W. Smit, Peter Basile, Maria Key Prato et al. · Movement Disorders · 2022 · 51 citations · Full text

Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection

Concepción Palomo, Vicente Más, Laurent Detalle et al. · Antimicrobial Agents and Chemotherapy · 2016 · 36 citations · Full text

Rows per page

1–5 of 11